Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Levan, Kristina"'
Autor:
Levan, Kristina
Diss. (sammanfattning) Göteborg : Univ., 2009.
Härtill 4 uppsatser.
Härtill 4 uppsatser.
Externí odkaz:
http://hdl.handle.net/2077/19401
Publikováno v:
In Gynecologic Oncology October 2013 131(1):52-58
Publikováno v:
In Cancer Genetics and Cytogenetics 2008 181(1):25-30
Autor:
Levan, Kristina1,2 kristina.levan@gu.se, Mehryar, Matin1, Mateoiu, Constantina3, Albertsson, Per4, Bäck, Tom5, Sundfeldt, Karin1
Publikováno v:
BMC Cancer. 5/2/2017, Vol. 17, p1-10. 10p. 1 Chart, 4 Graphs.
Autor:
Österberg, Lovisa, Åkeson, Margaretha, Levan, Kristina, Partheen, Karolina, Zetterqvist, Britt-Marie, Brännström, Mats, Horvath, György
Publikováno v:
In Cancer Genetics and Cytogenetics 2006 167(2):103-108
Publikováno v:
In Cancer Genetics and Cytogenetics 2005 163(2):144-150
Autor:
Olsson Björn, Delle Ulla, Partheen Karolina, Levan Kristina, Österberg Lovisa, Sundfeldt Karin, Horvath György
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 368 (2009)
Abstract Background Chemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive markers of chemoresponse would help to individualize therapy and improve survival of ovarian cancer patients.
Externí odkaz:
https://doaj.org/article/c2496e639d82495ea8d1d7a4d5116cca
Autor:
Sundfeldt Karin, Claesson Ingela, Österberg Lovisa, Levan Kristina, Partheen Karolina, Horvath György
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 336 (2009)
Abstract Background The majority of women with ovarian cancer are diagnosed in late stages, and the mortality rate is high. The use of biomarkers as prognostic factors may improve the treatment and clinical outcome of these patients. We performed an
Externí odkaz:
https://doaj.org/article/c4b3ded2a2744ea7a27a5ba866de42b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Levan, Kristina
Endometrial carcinoma is the most common malignancy in the female reproductive tract. In Sweden over 1300 women are diagnosed every year, and although the prognosis is favourable in the majority of cases, about 160 patients die of the disease every y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1149::658238790f06d50a154e1d4e8d3ec25c